Advisory Board September 12, 2023

FDA on Monday approved new COVID-19 vaccines for this fall. And with CDC expected to offer a recommendation soon, the shots could be available in pharmacies, clinics, and doctor’s offices by the end of the week.

FDA approves new COVID-19 shots

The new monovalent shots, which were developed by Moderna and Pfizer-BioNTech, target the XBB.1.5 subvariant of omicron and were approved for everyone ages 6 months and older.

Health officials noted the vaccine is not a booster shot but actually an entirely new formula.

“The public can be assured that these updated vaccines have met the agency’s rigorous...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
KFF Global Health Budget Summaries - 3
NIH Cuts Funding For Vaccine Hesitancy Research, Amid Measles Outbreak
Congress passes Full-Year Continuing Resolution Bill, maintaining global health funding at prior year levels
Seeing Public Health as an Investment in People and Communities
HIV could infect 1,400 infants every day because of US aid disruptions

Share This Article